A most educative cross-Atlantic retrospective study on an always important question. The short accompanying video is also valuable!
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Surgery
August 13, 2019
August 9, 2019
Retrospectively using a longitudinal echocardiography database, the authors analyzed the data of 3,276 patients with isolated severe tricuspids regurgitation (TR) from 2001 through 2016. Of these patients, 5% underwent tricuspid valve surgery.
August 8, 2019
A detailed and robust meta-analysis asserting lack of strong evidence supporting either modality.
August 7, 2019
The authors in this study ask—given the known racial disparities in the US healthcare system—what happens in a universal insurance program like TRICARE in terms of quality of care after coronary artery bypass grafting (CABG)?
August 1, 2019
In this article, Umana-Pizana et al performed a phases-of-care mortality analysis amongst 5141 cardiac surgery cases with a 4.6% crude mortality in a population with a median STS risk score of 5.8%.
August 1, 2019
Corsini et al examined the results of a single-institution's 5-year experience of cardiothoracic surgery mock oral examinations.
July 11, 2019
An important update on the evolving landscape of surgery for atrial fibrillation.
October 23, 2018
Farhood Saremi and colleagues from the University of Southern California contributed a comprehensive review of the computed tomography angiographic (CTA) findings that improve the accuracy of diagnosis of thoracic aortic dissection and predict the outcomes of different management strategies for this highly lethal disease.
June 15, 2018
Patient Care and General Interest
Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery
March 26, 2018
Hassan and colleagues performed a retrospective analysis of 81 patients who presented for open cardiac surgery while receiving novel oral anticoagulant (NOAC) therapy. Patients were off NOACs for a median of 4 days (IQR, 3 - 6 days) prior to surgery.